Synonyms: AQW-051 | VQW 765 | VQW-765 | VQW765
Compound class:
Synthetic organic
Comment: AQW 051 is an α7 nicotinic acetylcholine receptor (nAChR) partial agonist from Novartis for the oral treatment of cognitive deficits in schizophrenia, Alzheimer's, and Parkinson's diseases [1,3]. Structure first disclosed at March 2014 ACS meeting. The (3S) version is CID 71553840. The compound was later re-named to VQW-765 (Vanda Pharmaceuticals).
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
(3R)-3-{[6-(4-methylphenyl)pyridin-3-yl]oxy}-1-azabicyclo[2.2.2]octane |
Synonyms |
AQW-051 | VQW 765 | VQW-765 | VQW765 |
Database Links | |
BindingDB Ligand | 50520725 |
CAS Registry No. | 669770-29-0 (source: Scifinder) |
ChEMBL Ligand | CHEMBL4532388 |
GtoPdb PubChem SID | 178103943 |
PubChem CID | 50914822 |
Search Google for chemical match using the InChIKey | NPDLTEZXGWRMLQ-IBGZPJMESA-N |
Search Google for chemicals with the same backbone | NPDLTEZXGWRMLQ |
UniChem Compound Search for chemical match using the InChIKey | NPDLTEZXGWRMLQ-IBGZPJMESA-N |
UniChem Connectivity Search for chemical match using the InChIKey | NPDLTEZXGWRMLQ-IBGZPJMESA-N |